Inventor · disambiguated record
Hanne Bak
Also filed as: BAK HANNE
7 granted patents·11 pending applications·61 citations·filing 2015–2025
83Inventor score
Files withREGENERON PHARMA18
Top patents by PatentIndex Score
18 records- 0195US10342876B2Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2015·Granted Jul 9, 2019·17 cites·21 claims
- 0294US10626142B2Purification platform for bispecific antibodiesREGENERON PHARMA·Filed 2015·Granted Apr 21, 2020·34 cites·40 claims
- 0392US11333642B2Methods and systems for chromatography data analysisREGENERON PHARMA·Filed 2020·Granted May 17, 2022·3 cites·20 claims
- 0488US10613063B2Methods and systems for chromatography data analysisREGENERON PHARMA·Filed 2017·Granted Apr 7, 2020·3 cites·21 claims
- 0586US12152056B2Method and chromatography system for determining amount and purity of a multimeric proteinREGENERON PHARMA·Filed 2019·Granted Nov 26, 2024·4 cites·6 claims
- 0684US2024415969A1Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0782US2023348532A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0882US2023331776A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0982US2023332084A1Bioreactor for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1082US2023287043A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1182US2023332201A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1282US2024010737A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1380US2023273163A1Methods and systems for chromatography data analysisREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1480US2025281618A1Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1578US11680930B2Methods and systems for chromatography data analysisREGENERON PHARMA·Filed 2022·Granted Jun 20, 2023·0 cites·20 claims
- 1673US12070502B2Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2019·Granted Aug 27, 2024·0 cites·48 claims
- 1771US2025161457A1Process for reducing subvisible particles in a pharmaceutical formulationREGENERON PHARMA·Filed 2025·Application pending·0 cites
- 1835US2017191101A1Clarification of mammalian cell cultureREGENERON PHARMA·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hanne Bak files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →